Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Gouras, Gunnar K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PRION PROTEIN;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN REGION; CYTOLOGY; DEGENERATIVE DISEASE; ENDOSOME; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROPATHOLOGY; PARKINSON DISEASE; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; REVIEW; SYNAPSE;

EID: 84888863049     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/141083     Document Type: Review

References (57)

1. Mucke L., Selkoe D. J., Neurotoxicity of amyloid β -protein: synaptic and network dysfunction. Cold Spring Harbor Perspectives in Medicine 2012 2 7 10.1101/cshperspect.a006338 a006338
2. Gouras G. K., Tampellini D., Takahashi R. H., Capetillo-Zarate E., Intraneuronal β -amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathologica 2010 119 5 523 541 2-s2.0-77953019895 10.1007/s00401-010-0679-9
3. Bellucci A., Zaltieri M., Navarria L., Grigoletto J., Missale C., Spano P., From α -synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Brain Research 2012 1476 183 202 2-s2.0-84860559568 10.1016/j.brainres.2012.04.014
4. Stefanis L., α -Synuclein in Parkinson's disease. Cold Spring Harbor Perspectives in Medicine 2012 2 2 10.1101/cshperspect.a009399 009399
5. Haass C., Kaether C., Thinakaran G G., Sisodia S., Trafficking and proteolytic processing of APP. Cold Spring Harbor Perspectives in Medicine 2012 2 5 10.1101/cshperspect.a006270 006270
6. Lah J. J., Heilman C. J., Nash N. R., Rees H. D., Yi H., Counts S. E., Levey A. I., Light and electron microscopic localization of presenilin-1 in primate brain. The Journal of Neuroscience 1997 17 6 1971 1980 2-s2.0-0031017795 (Pubitemid 27106756)
7. Zheng H., Jiang M., Trumbauer M. E., Sirinathsinghji D. J. S., Hopkins R., Smith D. W., Heavens R. P., Dawson G. R., Boyce S., Conner M. W., Stevens K. A., Slunt H. H., Sisodia S. S., Chen H. Y., Van der Ploeg L. H. T., β -amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995 81 4 525 531 2-s2.0-0028988801
8. Chiesa R., Harris D. A., Fishing for prion protein function. PLoS Biology 2009 7 3 0439 0443 2-s2.0-65949083115 10.1371/journal.pbio.1000075
9. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R., APP processing and synaptic function. Neuron 2003 37 6 925 937 2-s2.0-0344672942 10.1016/S0896-6273(03)00124-7 (Pubitemid 36398299)
10. Tampellini D., Rahman N., Gallo E. F., Huang Z., Dumont M., Capetillo-Zarate E., Ma T., Zheng R., Lu B., Nanus D. M., Lin M. T., Gouras G. K., Synaptic activity reduces intraneuronal A β promotes APP transport to synapses, and protects against A β -related synaptic alterations. The Journal of Neuroscience 2009 29 31 9704 9713 2-s2.0-68549127183 10.1523/JNEUROSCI.2292-09.2009
11. Tampellini D., Capetillo-Zarate E., Dumont M., Huang Z., Yu F., Lin M. T., Gouras G. K., Effects of synaptic modulation on β -amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. The Journal of Neuroscience 2010 30 43 14299 14304 2-s2.0-78049349176 10.1523/JNEUROSCI.3383-10.2010
12. Ihara Y., Morishima-Kawashima M., Nixon R., The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012 2 8 10.1101/cshperspect.a006361
13. Ehlers M. D., Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nature Neuroscience 2003 6 3 231 242 2-s2.0-0037374587 10.1038/nn1013 (Pubitemid 36278281)
14. Bahr B. A., Bendiske J., The neuropathogenic contributions of lysosomal dysfunction. Journal of Neurochemistry 2002 83 3 481 489 2-s2.0-0036830228 10.1046/j.1471-4159.2002.01192.x (Pubitemid 35231802)
15. Cataldo A. M., Peterhoff C. M., Troncoso J. C., Gomez-Isla T., Hyman B. T., Nixon R. A., Endocytic pathway abnormalities precede amyloid β deposition in sporadic alzheimer's disease and down syndrome: differential effects of APOE genotype and presenilin mutations. American Journal of Pathology 2000 157 1 277 286 2-s2.0-0033869715 (Pubitemid 30641743)
16. Nixon R. A., Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends in Neurosciences 2006 29 9 528 535 2-s2.0-33747881231 10.1016/j.tins.2006.07.003 (Pubitemid 44291816)
17. Harrison D. E., Strong R., Sharp Z. D., Nelson J. F., Astle C. M., Flurkey K., Nadon N. L., Wilkinson J. E., Frenkel K., Carter C. S., Pahor M., Javors M. A., Fernandez E., Miller R. A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009 460 7253 392 395 2-s2.0-67650944993 10.1038/nature08221
18. Caccamo A., Majumder S., Richardson A., Strong R., Oddo S., Molecular interplay between mammalian target of rapamycin (mTOR), amyloid- β and Tau: effects on cognitive impairments. Journal of Biological Chemistry 2010 285 17 13107 13120 2-s2.0-77951227122 10.1074/jbc.M110.100420
19. Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V., Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid- β levels in a mouse model of alzheimer's disease. PLoS ONE 2010 5 4 2-s2.0-77956305343 10.1371/journal.pone.0009979 e9979
20. Ma T., Hoeffer C. A., Capetillo-Zarate E., Yu F., Wong H., Lin M. T., Tampellini D., Klann E., Blitzer R. D., Gouras G. K., Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS ONE 2010 5 9 1 10 2-s2.0-77958465822 10.1371/journal.pone.0012845 e12845
21. Park M., Penick E. C., Edwards J. G., Kauer J. A., Ehlers M. D., Recycling endosomes supply AMPA receptors for LTP. Science 2004 305 5692 1972 1975 2-s2.0-4644287672 10.1126/science.1102026 (Pubitemid 39287999)
22. Rajendran L., Annaert W., Membrane trafficking pathways in Alzheimer's disease. Traffic 2012 13 6 759 770 2-s2.0-84857027865 10.1111/j.1600-0854.2012. 01332.x
23. Takahashi R. H., Milner T. A., Li F., Nam E. E., Edgar M. A., Yamaguchi H., Beal M. F., Xu H., Greengard P., Gouras G. K., Intraneuronal Alzheimer A β 42 accumulates in multivesicular bodies and is associated with synaptic pathology. American Journal of Pathology 2002 161 5 1869 1879 2-s2.0-0036827031 (Pubitemid 35265544)
24. Takahashi R. H., Almeida C. G., Kearney P. F., Yu F., Lin M. T., Milner T. A., Gouras G. K., Oligomerization of Alzheimer's β -amyloid within processes and synapses of cultured neurons and brain. The Journal of Neuroscience 2004 24 14 3592 3599 2-s2.0-1842732209 10.1523/JNEUROSCI.5167-03. 2004 (Pubitemid 38481116)
25. Capetillo-Zarate E., Gracia L., Yu F., Banfelder J. R., Lin M. T., Tampellini D., Gouras G. K., High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils. American Journal of Pathology 2011 179 5 2551 2558 2-s2.0-80054974015 10.1016/j.ajpath.2011.07.045
26. Almeida C. G., Takahashi R. H., Gouras G. K., β -amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. The Journal of Neuroscience 2006 26 16 4277 4288 2-s2.0-33646461282 10.1523/JNEUROSCI.5078-05.2006 (Pubitemid 44315387)
27. Skibinski G., Parkinson N. J., Brown J. M., Chakrabarti L., Lloyd S. L., Hummerich H., Nielsen J. E., Hodges J. R., Spillantini M. G., Thusgaard T., Brandner S., Brun A., Rossor M. N., Gade A., Johannsen P., Sørensen S. A., Gydesen S., Fisher E. M. C., Collinge J., Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nature Genetics 2005 37 8 806 808 2-s2.0-23044471011 10.1038/ng1609 (Pubitemid 41077105)
28. Pooler A. M., Phillips E. C., Lau D. H., Noble W., Hanger D. P., Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Reports 2013 14 4 389 394 10.1038/embor.2013.15
29. Frost B., Diamond M. I., Prion-like mechanisms in neurodegenerative diseases. Nature Reviews Neuroscience 2010 11 3 155 159 2-s2.0-77249133010 10.1038/nrn2786
30. Cossec J.-C., Marquer C., Panchal M., Lazar A. N., Duyckaerts C., Potier M.-C., Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Biochimica et Biophysica Acta 2010 1801 8 839 845 2-s2.0-77953273656 10.1016/j.bbalip.2010.03.010
31. Grösgen S., Grimm M. O. W., Frieß P., Hartmann T., Role of amyloid beta in lipid homeostasis. Biochimica et Biophysica Acta 2010 1801 8 966 974 2-s2.0-77953279456 10.1016/j.bbalip.2010.05.002
32. Hedskog L., Pinho C. M., Filadi R., Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proceedings of the National Academy of Sciences of the United States of America 2013 110 19 7916 7921 10.1073/pnas.1300677110
33. Li J., Kanekiyo T., Shinohara M., Differential regulation of amyloid- β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. Journal of Biological Chemistry 2012 287 53 44593 44601 10.1074/jbc.M112.420224
34. Kuszczyk M. A., Sanchez S., Pankiewicz J., Blocking the interaction between apolipoprotein E and A β reduces intraneuronal accumulation of A β and inhibits synaptic degeneration. American Journal of Pathology 2013 182 5 1750 1768 10.1016/j.ajpath.2013.01.034
35. Melman L., Geuze H. J., Li Y., McCormick L. M., Van Kerkhof P., Strous G. J., Schwartz A. L., Bu G., Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway. Molecular Biology of the Cell 2002 13 9 3325 3335 2-s2.0-0036732911 10.1091/mbc.E02-03-0152 (Pubitemid 35034266)
36. Zou W.-Q., Cashman N. R., Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form. Journal of Biological Chemistry 2002 277 46 43942 43947 2-s2.0-0037113898 10.1074/jbc.M203611200 (Pubitemid 36157818)
37. Gorman P. M., Yip C. M., Fraser P. E., Chakrabartty A., Alternate aggregation pathways of the Alzheimer β -amyloid peptide: A β association kinetics at endosomal pH. Journal of Molecular Biology 2003 325 4 743 757 2-s2.0-0037462946 10.1016/S0022-2836(02)01279-2 (Pubitemid 36277655)
38. Stine W. B. Jr., Dahlgren K. N., Krafft G. A., LaDu M. J., In vitro characterization of conditions for amyloid- β peptide oligomerization and fibrillogenesis. Journal of Biological Chemistry 2003 278 13 11612 11622 2-s2.0-0038176528 10.1074/jbc.M210207200 (Pubitemid 36792723)
39. Yang A. Y., Chandswangbhuvana D., Margol L., Glabe C. G., Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid A β 1-42 pathogenesis. Journal of Neuroscience Research 1998 52 691 698 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 (Pubitemid 28300049)
40. Ditaranto K., Tekirian T. L., Yang A. J., Lysosomal membrane damage in soluble A β -mediated cell death in Alzheimer's disease. Neurobiology of Disease 2001 8 1 19 31 2-s2.0-0035110055 10.1006/nbdi.2000.0364 (Pubitemid 32171815)
41. Prusiner S. B., Cell biology. A unifying role for prions in neurodegenerative diseases. Science 2012 336 6088 1511 1513 10.1126/science. 1222951
42. Suzuki G., Shimazu N., Tanaka M., A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 2012 336 6079 355 359 2-s2.0-84859985750 10.1126/science.1219491
43. Wickner R. B., Edskes H. K., Kryndushkin D., McGlinchey R., Bateman D., Kelly A., Prion diseases of yeast: amyloid structure and biology. Seminars in Cell and Developmental Biology 2011 22 5 469 475 2-s2.0-80052800750 10.1016/j.semcdb.2011.02.021
44. Fowler D. M., Koulov A. V., Balch W. E., Kelly J. W., Functional amyloid-from bacteria to humans. Trends in Biochemical Sciences 2007 32 5 217 224 2-s2.0-34247899121 10.1016/j.tibs.2007.03.003 (Pubitemid 46694328)
45. Steele A. D., Lindquist S., Aguzzi A., The prion protein knockout mouse: a phenotype under challenge. Prion 2007 1 2 83 93 2-s2.0-43149121009
46. Jucker M., Walker L. C., Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Annals of Neurology 2011 70 4 532 540 2-s2.0-80054024011 10.1002/ana.22615
47. Stohr J., Watts J. C., Mensinger Z. L., Purified and synthetic Alzheimer's amyloid beta (A β) prions. Proceedings of the National Academy of Sciences of the United States of America 2012 109 27 11025 11030 10.1073/pnas.1206555109
48. Li J.-Y., Englund E., Holton J. L., Soulet D., Hagell P., Lees A. J., Lashley T., Quinn N. P., Rehncrona S., Björklund A., Widner H., Revesz T., Lindvall O., Brundin P., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Medicine 2008 14 5 501 503 2-s2.0-43249110200 10.1038/nm1746 (Pubitemid 351655211)
49. Luk K. C., Kehm V., Carroll J., Pathological α -synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012 338 6109 949 953 10.1126/science.1227157
50. Yang A. J., Chandswangbhuvana D., Shu T., Henschen A., Glabe C. G., Intracellular accumulation of insoluble, newly synthesized A β n-42 in amyloid precursor protein-transfected cells that have been treated with A β 1- 42. Journal of Biological Chemistry 1999 274 29 20650 20656 2-s2.0-0033575336 10.1074/jbc.274.29.20650 (Pubitemid 29340429)
51. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A., Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996 379 6563 339 343 2-s2.0-0030054010 10.1038/379339a0 (Pubitemid 26033075)
52. Mallucci G., Dickinson A., Linehan J., Klöhn P.-C., Brandner S., Collinge J., Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003 302 5646 871 874 2-s2.0-0242363656 10.1126/science.1090187 (Pubitemid 37339628)
53. Saavedra L., Mohamed A., Ma V., Kar S., De Chaves E. P., Internalization of β -amyloid peptide by primary neurons in the absence of apolipoprotein E. Journal of Biological Chemistry 2007 282 49 35722 35732 2-s2.0-37249062072 10.1074/jbc.M701823200 (Pubitemid 350277136)
54. Nath S., Agholme L., Kurudenkandy F. R., Granseth B., Marcusson J., Hallbeck M., Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β -amyloid. The Journal of Neuroscience 2012 32 26 8767 8777 10.1523/JNEUROSCI.0615-12.2012
55. Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P., Simons K., Alzheimer's disease β -amyloid peptides are released in association with exosomes. Proceedings of the National Academy of Sciences of the United States of America 2006 103 30 11172 11177 2-s2.0-33746593662 10.1073/pnas.0603838103 (Pubitemid 44156491)
56. Tampellini D., Rahman N., Lin M. T., Capetillo-Zarate E., Gouras G. K., Impaired β -amyloid secretion in Alzheimer's disease pathogenesis. The Journal of Neuroscience 2011 31 43 15384 15390 2-s2.0-80054890505 10.1523/JNEUROSCI.2986-11.2011
57. Irwin D. J., Abrams J. Y., Schonberger L. B., Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurology 2013 70 4 462 468 10.1001/jamaneurol.2013.1933